Invasive fungal laryngitis: A rare mimic of laryngeal cancer Authors: Sai Kiran Gudla, Anil Vasireddi Published: 2026 ABSTRACT AbstractPrimary fungal laryngitis is a very rare clinical entity that usually manifests in immunocompromised patients due to impaired protection of the laryngeal mucosal barrier. We report a case of a 65-year-old patient with bilateral lung transplantation who presented with subacute worsening cough, hoarseness and clinical findings of hypercapnic respiratory failure. Initial imaging from barium swallow showed a mass narrowing the upper airway with a subsequent CT neck exam confirming a new large, invasive glottic mass narrowing the airway, which was initially suspicious for an aggressive malignancy. Prompt tracheostomy was performed and biopsies showed invasive fungal infection with sputum cultures that grew Ochroconis gallopava. The mass subsequently decreased in size after antifungal treatment. Diagnosis of fungal laryngitis can be overlooked as it can mimic laryngeal neoplasms as well as inflammatory/granulomatous processes or sequela of laryngopharyngeal reflux in milder cases. However, prompt diagnosis is critical given potential for invasion, risk of airway obstruction and loss of laryngeal function.Keywords: Fungal laryngitis, Glottic mass, Dysphonia Introduction Case history The patient is a 65-year-old male with history of pulmonary fibrosis status post bilateral orthotopic lung transplant 2 years prior, esophageal dysmotility, constrictive pericarditis with reactive pleural effusions and remote history of Hodgkin’s lymphoma treated with chemotherapy. The patient is on daily oral steroids for transplant immunosuppression and trimethoprim-sulfamethaxozole for prophylaxis. The patient initially presented to the outpatient transplant pulmonology office with severe recurrent aspiration, worsening cough, hoarseness and difficulty swallowing. These symptoms had been present for several months and he had recurrent admissions for similar concerns. At the time, the symptoms were believed to be from recurrent pleural effusions and constrictive pericarditis. The patient was hemodynamically stable and afebrile. Labs showed pulmonary function tests with restrictive physiology and venous blood gas with signs of hypercapnic respiratory failure. The patient was on supplemental oxygen at home. Given his progressive symptoms with concern for failure to thrive, the patient was transferred to the inpatient service for further evaluation. Initially, a barium swallow was performed given his history of reflux and clinical concern for esophageal dysmotility. This study revealed intratracheal aspiration of the barium and allowed for visualization of a proximal airway mass possibly near the upper trachea on the scout imaging (Fig. 1). A CT neck soft tissue with contrast study was obtained and revealed a large transglottic mass centered within the anterior larynx without appreciable enhancement. The mass demonstrated invasion into the paraglottic soft tissues and thyroid cartilage, with evidence of destruction and expansion of the thyroid cartilage (Fig. 2). Mass effect resulted in severe laryngeal and upper tracheal narrowing concerning for upper airway obstruction. Imaging findings initially raised suspicion for underlying laryngeal cancer. Interestingly, these findings were all new compared to a CT performed only 6 weeks prior (Fig. 3). This rate of progression was atypical for a neoplasm and was more suggestive of an invasive infectious process. Scout radiograph of the barium swallow study shows suggestion of a partially calcified mass causing moderate narrowing of the laryngopharynx (blue arrow). Axial and sagittal CT neck soft tissue with contrast shows an ill-defined glottic mass without appreciable enhancement with invasion and destruction of the adjacent thyroid cartilage. There is severe stenosis of the glottic airway. Axial CT chest exam with contrast obtained for evaluation of dyspnea about 6 weeks prior to Figure 2 showed no evidence of the laryngeal pathology at the time. The otolaryngology team was consulted and a bedside endoscopy revealed a predominantly submucosal transglottic mass with friable overlying mucosa resulting in obstruction of the larynx. Emergent tracheostomy was then performed for protection of the airway. Surgical biopsies of the laryngeal mass were obtained with tissue histopathology showing signs of mixed invasive fungal infection with budding yeast and pigmented fungal hyphae. Speciation was not performed on the surgical biopsy sample. However subsequent sputum cultures with fungal speciation grew Ochroconis gallopava, a darkly pigmented mold. This was thought to be the primary infectious agent within the laryngeal mass. Susceptibility testing was not performed. Bacterial sputum cultures were negative although bronchial alveolar lavage showed growth of Gram positive cocci suggestive of concomitant pulmonary infection. He was started on a broad antifungal regimen of voriconazole, micafungin, and inhaled amphotericin. While discussion was made about possible laryngectomy with the patient, the decision was made to proceed with antifungal treatment and monitor the laryngeal mass. His ventilatory requirements initially improved with transition to tracheostomy collar trials. A repeat CT neck one month later showed a noticeable decrease in size of the mass while on antifungal therapy (Fig. 4). However, his clinical status deteriorated to the point where he needed high inspiratory pressures to support his ventilation. A multidisciplinary discussion with the patient and family took place and the patient elected his wishes to not be on a long-term ventilator. The patient subsequently passed due to respiratory failure while under palliation. Axial and sagittal CT neck soft tissue with contrast approximately 1 month after Figure 2 following administration of broad-spectrum antifungal therapy. There is a decrease in size of the mass with less anterior bowing of the overlying strap muscles, improved patency of the larynx, and near complete resolution of the paraglottic component of this mass compared with Figure 2. There are persistent erosions of the thyroid cartilage. Discussion Primary fungal laryngitis is a rare disease typically seen among patients in an immunocompromised state including systemic corticosteroid use, chemotherapy, AIDS, diabetes, advanced age, or hematologic malignancy [1]. It has also been described in immunocompetent patients, typically associated with other conditions resulting in impairment of mucosal barrier to infection including prior history of radiation to the neck, trauma, inhaled corticosteroid use or chronic gastroesophageal reflux disease [2]. In our case, the patient had taken oral steroids for post-transplant immunosuppression. This disease often presents with hoarseness and cough with duration of symptoms ranging from weeks to months [3]. It can also present acutely in instances of airway compromise requiring urgent tracheostomy, as demonstrated in our case. Damage to laryngeal structures in severe cases can result in vocal cord paralysis and dysfunction. Thus, prompt diagnosis is key even though it can be challenging due to overlapping imaging and endoscopic features with malignancy and inflammatory diseases in the airway. Imaging findings of fungal laryngitis can range from subtle in cases of limited disease or severe and invasive, as demonstrated in this case and others described in literature [[2], [3], [4], [5]]. Findings can be indistinguishable from other laryngeal pathologies including malignancies (eg, squamous cell carcinoma, lymphoma), benign leukoplakia and granulomatous diseases (eg, sarcoidosis) [5,6]. The glottis is the most common site of initial infectious seeding within the larynx, possibly due to repetitive mucosal microtrauma involving the vocal cords [7]. Infection can then spread into paraglottic soft tissues, thyroid and cricoid cartilages, and trachea. Necrosis related to invasive infection can even result in laryngotracheal separation [3]. MRI may be helpful in further characterizing the extent of disease and demonstrating T2 hypointense signal that is more typical of fungal masses. Endoscopic findings may also not be specific as white fungal patches can resemble squamous cell carcinoma and benign leukoplakic lesions [7]. Thus, biopsy for definitive histopathologic evaluation is needed to exclude malignancy and confirm this diagnosis. Fungal staining techniques, including Gomori-methanamine silver (GMS), Gram staining, potassium hydroxide (KOH), and periodic acid- Schiff staining (PAS) can be helpful in confirming this diagnosis to start empiric antifungal treatment prior to final determination of fungal species and antifungal sensitivities [1,8]. Common culprits of fungal laryngitis include Candida, aspergillus, cryptococcus, histoplasmosis and blastomycosis [1]. In this case, the invasive nature of the glottic mass initially raised the possibility of an underlying malignancy. However, absence of an appreciable enhancing component and rapid development over 6 weeks would be very atypical for neoplastic processes like squamous cell carcinoma or lymphoma. These imaging features would favor fungal infection over malignancy in the differential diagnosis. MRI was not performed due to the patient’s respiratory status and anticipated challenges with tolerating prolonged scan times. Tissue sampling was ultimately necessary for definitive characterization and revealed evidence of fungal infection with Ochroconis gallopava identified as the causal agent. O. gallopava is a thermophilic, dematiaceous mold typically found in soil, thermal springs and decaying vegetation [9]. Immunocompromised patients, especially those who have undergone solid organ transplantation, are at significantly higher risk for infection. Inhaled fungal spores result in initial infectious seeding typically involving the pulmonary system. O. gallopava is relatively resistant to antifungal therapy and host immunity due to the presence of melanin within its cell walls, which contributes to its brownish pigmentation. It is thermotolerant and capable of surviving at temperatures as high as 45°C, allowing it to maintain cellular integrity within the human body [10]. Infection localized to the lungs can typically be treated with a high rate of survival. However, dissemination of infection elsewhere in the body, most commonly to the brain, is associated with poor prognosis [9,10]. Management of this disease process requires a multidisciplinary approach including input from infectious disease and otolaryngology. Early initiation of antifungal therapy is crucial to halt disease progression and even result in improvement to the point of complete resolution [3]. In our case, the laryngeal mass decreased in size with just antifungal therapy based on endoscopic as well as imaging findings. Surgical debridement is sometimes considered to remove necrotic debris. Although no definite guidelines have been established, case reports have demonstrated utility of debridement in instances of limited disease for preservation of laryngeal function and also in severe cases of invasive disease with complete laryngeal necrosis, necessitating a total laryngectomy [3]. Patient comorbidity and tolerance for surgery must be considered in such decision making. In our case, a total laryngectomy was initially considered due to concerns related to a possible laryngeal carcinoma. However, following diagnosis of invasive fungal laryngitis, surgery was deferred due to the patient’s additional respiratory co-morbidities. A diagnosis of fungal laryngitis was strengthened by evidence of imaging improvement following initiation of antifungal therapy. Continued deterioration of the patient’s respiratory status was thought to be likely related to a superimposed bacterial pneumonia based on lavage results as opposed to the improving fungal laryngitis. Conclusion Fungal laryngitis is an important differential consideration for acute or subacute presentations of hoarseness with a rapidly enlarging laryngeal mass on imaging, particularly in patients who are immunocompromised. This disease must be excluded given its treatability and significantly different management approach from other more common etiologies such as laryngeal neoplasm. Rapid management is important to prevent loss of laryngeal function or more acutely, a loss of respiratory function. Patient consent The patient was deceased at time of creation of this case report. Informed consent was obtained from his wife and she gave permission to use the anonymized clinical information for publication. Footnotes Competing Interests: The authors have declared that no competing interests exist. References